Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000232
Status:
COMPLETED
Last Update Posted:
2016-05-06
First Post:
1999-09-20
Brief Title:
Alternate Day Buprenorphine Administration Phase IX - 14
Sponsor:
University of Vermont
Organization:
University of Vermont
Study Overview
Official Title:
Alternate Day Buprenorphine Administration Phase IX
Status:
COMPLETED
Status Verified Date:
1994-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if four times a subjects daily maintenance dose will hold for 120 hours without changes in agonist and antagonist effects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-06969-14 | US NIH GrantContract | None | httpsreporternihgovquickSearchR01DA006969 |
| R01DA006969 | NIH | None | None |